These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24869763)

  • 1. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
    Von Visger JR; Gunay Y; Andreoni KA; Bhatt UY; Nori US; Pesavento TE; Elkhammas EA; Winters HA; Nadasdy T; Singh N
    Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
    Di Vico MC; Messina M; Fop F; Barreca A; Segoloni GP; Biancone L
    Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
    Sato Y; Ishida H; Shimizu T; Tanabe K
    Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.
    Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA
    Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
    Aydin-Ghormoz EA; Perlmutter J; Koizumi N; Ortiz J; Faddoul G
    Clin Transplant; 2024 Jan; 38(1):e15225. PubMed ID: 38127110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS; Huh W; Park SK; Ahn C; Han JS; Kim S; Kim YS
    Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Leeaphorn N; Garg N; Khankin EV; Cardarelli F; Pavlakis M
    Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Induction Immunosuppression on the Recurrence of Primary IgA Nephropathy.
    Lee KW; Kim KS; Lee JS; Yoo H; Kim K; Park JB; Kwon GY; Kim SJ
    Transplant Proc; 2019 Jun; 51(5):1491-1495. PubMed ID: 31010698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
    Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC
    Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
    Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
    Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA
    Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT.
    Lemes-Canuto AP; de Sandes-Freitas TV; Medina-Pestana JO; Mastroianni-Kirsztajn G
    J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysis.
    Kadiyala A; Mathew AT; Sachdeva M; Sison CP; Shah HH; Fishbane S; Jhaveri KD
    Clin Transplant; 2015 Oct; 29(10):911-9. PubMed ID: 26190417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol.
    Ibrahim H; Rogers T; Casingal V; Sturdevant M; Tan M; Humar A; Gillingham K; Matas A
    Transplantation; 2006 Jan; 81(2):214-9. PubMed ID: 16436965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
    Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
    J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.